Notably, SPRR1B knockdown reversed the malignant phenotypes of BC cells promoted by decreasing miR-330-5p, thereby inhibiting the cancer-promoting effect of HAGLROS (Supplementary Figure 3). The gene discussed is SPRR1B; the disease is breast cancer.